Medical network - on April 26, circulation market monstrous waves, the province 297 drug or collective collapse! 

 

▍ 35 billion circulation market in guangxi, 90% for top medicine group 

 

Recently, the guangxi health office issued the deepening medical and health system reform in guangxi "much starker choices-and graver consequences-in planning" (hereinafter referred to as planning. 

 

"Planning", said: the implementation of drug purchase "two votes" reform; The years 2020 to establish the ex-factory price of basic information recourse mechanism, form more than 1 year sales of more than 10 billion large medicine circulation enterprises, pharmaceutical wholesale enterprises annual sales accounted for more than 90% of the total amount of the wholesale market. 

 

In the ministry of commerce issued 2015 medicine circulation industry to run statistical analysis report, there are 298 pharmaceutical wholesale enterprises in guangxi, the province circulation market sales for 24 billion. Is also in the report released by the national medicine group of top, only this one in guangxi, guangxi liuzhou pharmaceutical co., LTD., the annual sales of 6.5 billion yuan. Growth rate of 8% per year, by the year 2020 in guangxi is 35 billion market, a company will eat nearly three. 

 

According to the "plan" in guangxi: a company will eat nearly 3 into a share; Other top drug batch split the rest of the market; For guangxi local only bear 297 medicine group of companies. 

 

▍, 297 drug manufacturers or collective collapse 

 

The "planning", there will be a big top, sought, the local situation. In fact, this is not the goal of individual provinces, but the planning of the state council. 

 

On January 9, printed and distributed by the state council "" much starker choices-and graver consequences-in" deepening the reform of medical health system planning "mentioned in the" strive for to 2020, pharmaceutical wholesale enterprises annual sales accounted for more than 90% of the total amount of the wholesale market." In the ministry of commerce of the national medicine circulation industry development planning (2016-2020) ", also has the same expression. 

 

Cruelty is the same, in the release of the planning of hubei province in February, 800 drug and only 10% of the market. As more and more provinces, driven by small and medium-sized medicine group or survive, or bankruptcy, or is the fate of the enterprises purchase annexation approaches. Since 2017, the currency market will be a big feast. 

 

However, for big drug companies tend to be the phenomenon of monopoly, the blue parker micro friends expressed different opinions: 

 

The other shore paradise: wrong! Small and medium-sized manufacturers and fail, die are the giant! 

 

Spinning: without the participation of small vendors, there is no the price fluctuations and the resources only in a few hands prices is only a word. Everyone to be seen! 

 

The doorbell meet: old provincial state-owned company, the listed company, which is not a giant? Because of planned economy, mechanism not to live, the burden is too much, was eventually, bankruptcy, dissolution and restructuring. Thirty years hedong hexi thirty years, the tables have turned. In twenty years, still have to separate. 

 

▍ drugs ex-factory price open, in, health care communication platform, or entered the countdown 

 

In addition, the "planning" of guangxi also response to the policy of the state council and the ministry of commerce: "set up the mechanism of drugs ex-factory price information recourse". Drugs ex-factory price transparency, entered the countdown. 

 

According to the blue parker the scoop on March 19, brewing a year's drugs ex-factory price information traceability policy is expected to be formally launched before the end of June. (please click past reports: price big wear bottom, published by the state file will!) 

 

Executives have repeatedly asked: a year ago, the state council executive meeting explicitly to speed up the drug prices traceable mechanism and promote drug price information, make the drug prices "transparent". 

 

After 3 months, the state development planning commission, national development and reform commission, the state food administration of drug safety and 9 departments jointly issued by the correct unhealthy tendencies in pharmaceutical sales and medical services in 2016 special projects work key point and issued by the general office of the state council in February "on further reform and improve the pharmaceutical production circulation use policy several opinions, all have the same requirements. 

 

Described according to the report, in June, the agency will take the lead in starting establish drugs ex-factory price information traceability system. Drug procurement platform, medical insurance payment platform, connectivity, tax data sharing.